Innovator IBD Breakout Opportunities ETF (BOUT)

Assets	$13.90M
Expense Ratio	0.85%
PE Ratio	39.61
Shares Out	350,000
Dividend (ttm)	$0.12
Dividend Yield	0.31%
Ex-Dividend Date	Dec 31, 2025
Payout Frequency	Annual
Payout Ratio	10.11%

Volume	930
Open	39.72
Previous Close	39.49
Day's Range	39.72 - 39.92
52-Week Low	31.08
52-Week High	41.16
Beta	1.01
Holdings	56
Inception Date	Sep 13, 2018

About BOUT

Fund Home Page

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is issued by Innovator.

• Asset Class: Equity
• Category: Mid-Cap Growth
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BOUT
• ETF Provider: Innovator
• Index Tracked: IBD Breakout Stocks Total Return

Top 10 Holdings

31.96% of assets

Name	Symbol	Weight
Sandisk Corporation	SNDK	3.61%
Carvana Co.	CVNA	3.37%
LivaNova PLC	LIVN	3.21%
Amentum Holdings, Inc.	AMTM	3.21%
Legence Corp.	LGN	3.17%
The Cheesecake Factory Incorporated	CAKE	3.14%
Dollar General Corporation	DG	3.13%
The Charles Schwab Corporation	SCHW	3.11%
Wayfair Inc.	W	3.01%
Moelis & Company	MC	3.00%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 31, 2025	$0.1249	Jan 2, 2026
Dec 31, 2024	$0.22753	Jan 2, 2025
Jul 31, 2024	$0.0059	Aug 1, 2024
Dec 28, 2023	$0.43704	Jan 2, 2024
Dec 29, 2022	$0.39823	Jan 3, 2023
Dec 27, 2018	$0.0389	Jan 2, 2019

Performance

BOUT had a total return of -4.02% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.92%.